Pass Rates Of China’s Random Drug Evaluation Hits 97% In 2011
This article was originally published in PharmAsia News
Random drug evaluations in China have achieved a pass rate of 97% for essential drugs and 96.8% for other medicines in 2011.
You may also be interested in...
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.